Shattuck Labs Inc
STTK
NASDAQ
Biotechnology
$7.42
USD
+0.10 (+1.37%)
At close: Aug 14, 2026, 4:00 PM EDT
Market Cap $661.53M
Volume 640.7K
Peer Comparison Table
(1/4) | ||||||
|---|---|---|---|---|---|---|
FTH | Faeth Therapeutics, Inc | $738.26M | - | - | - | |
IMMX | Immix Biopharma Inc | $721.15M | - | - | - | |
ALLO | Allogene Therapeutics Inc | $716.20M | - | - | - | |
RGNX | Regenxbio Inc | $692.15M | - | +12.0% | - | |
ACHV | Achieve Life Sciences Inc | $684.22M | - | -89.3% | - | |
STTK | Shattuck Labs Inc | $645.26M | - | -78.3% | - | |
CBIO | Crescent Biopharma Inc | $625.50M | - | - | - | |
MDXG | MiMedx Group Inc | $622.40M | 99.76 | -2.4% | - | |
NVCT | Nuvectis Pharma Inc | $614.98M | - | - | - | |
SPRY | ARS Pharmaceuticals Inc | $586.88M | - | +1.9% | - | |
ALT | Altimmune Inc | $586.09M | - | +80.0% | - |
Top Peer by Growth
Gyre Therapeutics Inc
+16.3% YoY Revenue
Lowest P/E Ratio
Rigel Pharmaceuticals Inc
2.42x P/E
Best 1-Year Return
Shattuck Labs Inc
+882.3% Return